Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) from a strong sell rating to a sell rating in a research report report published on Saturday.

Several other brokerages also recently commented on SENS. Weiss Ratings raised shares of Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, July 28th. HC Wainwright dropped their price target on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, May 12th. Stifel Nicolaus cut their price target on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, May 11th. Finally, Mizuho decreased their price objective on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $17.20.

Senseonics Holdings, Inc. Common Stock Price Performance

Shares of Senseonics Holdings, Inc. Common Stock stock opened at $7.54 on Friday. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62. The stock has a 50 day moving average of $5.87. The stock has a market cap of $315.17 million, a PE ratio of -3.38 and a beta of 1.01. Senseonics Holdings, Inc. Common Stock has a one year low of $4.79 and a one year high of $11.58.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.08). The company had revenue of $14.48 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. Sell-side analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Hedge funds have recently made changes to their positions in the business. Ausdal Financial Partners Inc. lifted its stake in Senseonics Holdings, Inc. Common Stock by 50.0% in the third quarter. Ausdal Financial Partners Inc. now owns 105,000 shares of the company’s stock worth $46,000 after acquiring an additional 35,000 shares during the period. GSK plc bought a new stake in Senseonics Holdings, Inc. Common Stock in the fourth quarter valued at $60,000. State of Wyoming purchased a new position in Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at $67,000. Kestra Advisory Services LLC bought a new position in Senseonics Holdings, Inc. Common Stock in the 1st quarter worth $68,000. Finally, Sanctuary Advisors LLC bought a new position in Senseonics Holdings, Inc. Common Stock in the 4th quarter worth $71,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.